Organ responses with daratumumab therapy in previously treated AL amyloidosis

Immunoglobulin light chain amyloidosis (AL amyloidosis) involves deposition of abnormally folded light chains into a wide range of tissues causing organ dysfunction, including in the heart and kidney. Daratumumab, a CD38-targeted antibody, has recently demonstrated efficacy in producing hematologic...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Blood Adv
मुख्य लेखकों: Chung, Alfred, Kaufman, Gregory P., Sidana, Surbhi, Eckhert, Erik, Schrier, Stanley L., Lafayette, Richard A., Arai, Sally, Witteles, Ronald M., Liedtke, Michaela
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Hematology 2020
विषय:
Lymphoid Neoplasia
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7013253/
https://ncbi.nlm.nih.gov/pubmed/32027745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000776
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन